Labcorp announces 2025 second quarter results

Raises full-year guidance financial results from operations for second quarter 2025 versus second quarter 2024: revenue: $3.53 billion versus $3.22 billion diluted eps: $2.84 versus $2.43 adjusted eps: $4.35 versus $3.94 raised enterprise revenue, adjusted eps and free cash flow guidance: revenue guidance narrowed to 7.5% to 8.6%; midpoint raised by 70 basis points adjusted eps range narrowed to $16.05 to $16.50; midpoint raised by $0.23 free cash flow range of $1.13 billion to $1.28 billion; midpoint raised by $25 million broadened our partnerships with hospitals, health systems and regional/local labs and enhanced access to comprehensive testing and laboratory services introduced several new tests in high-growth specialty areas including oncology burlington, n.c. , july 24, 2025 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended june 30, 2025 and raised full-year guidance.
LH Ratings Summary
LH Quant Ranking